152 related articles for article (PubMed ID: 26581861)
1. Novel transcripts reveal a complex structure of the human TRKA gene and imply the presence of multiple protein isoforms.
Luberg K; Park R; Aleksejeva E; Timmusk T
BMC Neurosci; 2015 Nov; 16():78. PubMed ID: 26581861
[TBL] [Abstract][Full Text] [Related]
2. TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma.
Tacconelli A; Farina AR; Cappabianca L; Desantis G; Tessitore A; Vetuschi A; Sferra R; Rucci N; Argenti B; Screpanti I; Gulino A; Mackay AR
Cancer Cell; 2004 Oct; 6(4):347-60. PubMed ID: 15488758
[TBL] [Abstract][Full Text] [Related]
3. Tissue-specific alternative splicing generates two isoforms of the trkA receptor.
Barker PA; Lomen-Hoerth C; Gensch EM; Meakin SO; Glass DJ; Shooter EM
J Biol Chem; 1993 Jul; 268(20):15150-7. PubMed ID: 8325889
[TBL] [Abstract][Full Text] [Related]
4. Expression of Trk isoforms in brain regions and in the striatum of patients with Alzheimer's disease.
Dubus P; Faucheux B; Boissière F; Groppi A; Vital C; Vital A; Agid Y; Hirsch EC; Merlio JP
Exp Neurol; 2000 Oct; 165(2):285-94. PubMed ID: 10993689
[TBL] [Abstract][Full Text] [Related]
5. The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells.
Farina AR; Tacconelli A; Cappabianca L; Cea G; Chioda A; Romanelli A; Pensato S; Pedone C; Gulino A; Mackay AR
Oncogene; 2009 Nov; 28(46):4075-94. PubMed ID: 19734938
[TBL] [Abstract][Full Text] [Related]
6. Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in neuroblastoma.
Tacconelli A; Farina AR; Cappabianca L; Gulino A; Mackay AR
Future Oncol; 2005 Oct; 1(5):689-98. PubMed ID: 16556046
[TBL] [Abstract][Full Text] [Related]
7. Type I interferons up-regulate the expression and signalling of p75 NTR/TrkA receptor complex in differentiated human SH-SY5Y neuroblastoma cells.
Dedoni S; Olianas MC; Ingianni A; Onali P
Neuropharmacology; 2014 Apr; 79():321-34. PubMed ID: 24333329
[TBL] [Abstract][Full Text] [Related]
8. Human TrkB gene: novel alternative transcripts, protein isoforms and expression pattern in the prefrontal cerebral cortex during postnatal development.
Luberg K; Wong J; Weickert CS; Timmusk T
J Neurochem; 2010 May; 113(4):952-64. PubMed ID: 20193039
[TBL] [Abstract][Full Text] [Related]
9. Multiple combinations of alternatively spliced exons in rat tropomyosin-alpha gene mRNA: evidence for 20 new isoforms in adult tissues and cultured cells.
Cooley BC; Bergtrom G
Arch Biochem Biophys; 2001 Jun; 390(1):71-7. PubMed ID: 11368517
[TBL] [Abstract][Full Text] [Related]
10. The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma.
Cappabianca L; Zelli V; Pellegrini C; Sebastiano M; Maccarone R; Clementi M; Chiominto A; Ruggeri P; Cardelli L; Ruggieri M; Sbaffone M; Fargnoli MC; Guadagni S; Farina AR; Mackay AR
Cells; 2023 Jan; 12(2):. PubMed ID: 36672171
[TBL] [Abstract][Full Text] [Related]
11. Direct effects of nerve growth factor on thecal cells from antral ovarian follicles.
Dissen GA; Parrott JA; Skinner MK; Hill DF; Costa ME; Ojeda SR
Endocrinology; 2000 Dec; 141(12):4736-50. PubMed ID: 11108289
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of congenital insensitivity to pain with anhidrosis (CIPA): mutations and polymorphisms in TRKA (NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor.
Indo Y
Hum Mutat; 2001 Dec; 18(6):462-71. PubMed ID: 11748840
[TBL] [Abstract][Full Text] [Related]
13. Novel Kidins220/ARMS Splice Isoforms: Potential Specific Regulators of Neuronal and Cardiovascular Development.
Schmieg N; Thomas C; Yabe A; Lynch DS; Iglesias T; Chakravarty P; Schiavo G
PLoS One; 2015; 10(6):e0129944. PubMed ID: 26083449
[TBL] [Abstract][Full Text] [Related]
14. TrkA-expressing trigeminal sensory neurons display both neurochemical and structural plasticity despite a loss of p75NTR function: responses to normal and elevated levels of nerve growth factor.
Krol KM; Stein EJ; Elliott J; Kawaja MD
Eur J Neurosci; 2001 Jan; 13(1):35-47. PubMed ID: 11135002
[TBL] [Abstract][Full Text] [Related]
15. Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells.
Edsjö A; Hallberg B; Fagerström S; Larsson C; Axelson H; Påhlman S
Cell Growth Differ; 2001 Jan; 12(1):39-50. PubMed ID: 11205744
[TBL] [Abstract][Full Text] [Related]
16. Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain.
Terry A; Kilbey A; Vaillant F; Stewart M; Jenkins A; Cameron E; Neil JC
Gene; 2004 Jul; 336(1):115-25. PubMed ID: 15225881
[TBL] [Abstract][Full Text] [Related]
17. Expression of GFRalpha1 receptor splicing variants with different biochemical properties is modulated during kidney development.
Charlet-Berguerand N; Le Hir H; Incoronato M; di Porzio U; Yu Y; Jing S; de Franciscis V; Thermes C
Cell Signal; 2004 Dec; 16(12):1425-34. PubMed ID: 15381258
[TBL] [Abstract][Full Text] [Related]
18. SHP-1 negatively regulates neuronal survival by functioning as a TrkA phosphatase.
Marsh HN; Dubreuil CI; Quevedo C; Lee A; Majdan M; Walsh GS; Hausdorff S; Said FA; Zoueva O; Kozlowski M; Siminovitch K; Neel BG; Miller FD; Kaplan DR
J Cell Biol; 2003 Dec; 163(5):999-1010. PubMed ID: 14662744
[TBL] [Abstract][Full Text] [Related]
19. Induction of nerve growth factor responsiveness in C6-2B glioma cells by expression of trkA proto-oncogene.
Colangelo AM; Fink DW; Rabin SJ; Mocchetti I
Glia; 1994 Oct; 12(2):117-27. PubMed ID: 7868185
[TBL] [Abstract][Full Text] [Related]
20. Impaired neurotrophin-3 signaling in a TrkAII mutant associated with hereditary polyneuropathy.
Flohr S; Ewers P; Fink GR; Weis J; Krüttgen A
Exp Neurol; 2010 Jul; 224(1):318-20. PubMed ID: 20188729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
